Key risks with CRISPR have migrated over time from concern about achieving end points in its trials, to whether the FDA would approve a CRISPR-based treatment, to know how successful that ...

CRISPR-Cas9 genome editing exploits the CRISPR ... Mathematical modelling suggests that it is theoretically possible to reduce risk of common diseases using heritable genome editing.

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

But it’s a slippery slope. When does reducing the risk of inherited breast cancer, diabetes, or Alzheimer’s disease edge into “designer baby” territory? As scientists grapple with the implications of ...

It can also modify gene expression, temporarily amplifying or diminishing its effects. Yet, despite its promise, applying CRISPR (which is a reagent, or a substance that facilitates a reaction ...

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...